Pathogenic variants in SGCB, encoding for beta-sarcoglycan, result in the recessive limb-girdle muscular dystrophy-4 (LGMDR4) form, displaying progressive weakening of proximal muscles in early childhood [5]. The gene discussed is SGCB; the disease is autosomal recessive limb-girdle muscular dystrophy type 2E.